Emerging technologies in therapeutic oligonucleotides
Tuesday 13 March 2018
MedImmune, AstraZeneca and GE Healthcare Life Sciences, in partnership with GSK, Roche, University of Oxford, BioMax and Academy of Pharmaceutical Sciences are pleased to invite you to their sixth oligonucleotide networking event. The title of this year's event is "Emerging technologies in therapeutic oligonucleotides". The meeting is kindly being hosted by MedImmune at their facility in Cambridge and is free to attend. There will be a networking drinks reception following the presentations, kindly sponsored by LGC Biosearch.
The focus of the 2018 meeting will be more in the discovery phase, with four main themes being covered throughout the day:
- CRISPR and Axiomer technologies
- Large molecule oligonucleotides
- drug delivery
- analytical and regulatory case studies
The meeting aims to bring together the community of interested professionals and practitioners in industry and academia to network, discuss the latest developments in this field, explore knowledge transfer issues and share best practise.
register online for your free place.